Dr.Samuel Strober specializes in the treatment of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. He has practiced rheumatology at Stanford for more than 30 years. He has special interests in the treatment of lupus kidney disease, and in eliminating the lifelong need for immunosuppressive drugs of organ transplant patients. He does not see patients in the Stanford out-patient clinics, but consults on Stanford in-patients with autoimmune disease and inflammatory arthritis. In addition, he consults on the medical tests that are required to determine the diagnosis and treatment of these diseases.
Dr. Strober's laboratory and clinical research interests are in the area of the molecular and cellular basis of the prevention of graft versus host disease while maintaining graft anti-tumor activity in recipients of bone marrow transplants, the induction of tolerance in recipients of combined organ and hematopoietic cell transplants, and the effective treatment of solid tumors and lymphoma with local tumor radiation regimens that induce potent anti-tumor immune responses. His laboratory research has been translated into ongoing clinical trials of organ and bone marrow transplantation at Stanford.
Program Director, NIH Program Project Grant (2004 - Present)
Member, Stanford Diabetes Research Center, Stanford University (2018 - Present)